Differential diagnosis of common subtypes of renal cell carcinoma based on corrected CT value and relative enhancement rate in multi-slice spiral CT

Jia CHEN,Xi ZHANG,Mingfu GONG,Li WEN

DOI: https://doi.org/10.16016/j.1000-5404.202004008

2020-01-01

Abstract:Objective To explore the feasibility of differentiating 4 common subtypes of renal cell carcinoma based on corrected CT value and relative enhancement rate in spiral CT multi-phase scanning. Methods We retrospectively analyzed the clinical data of 76 patients with pathologically confirmed renal cell carcinoma, including 28 with clear cell renal cell carcinoma (ccRCC), 24 with papillary renal cell carcinoma type Ⅰ (PRCCⅠ), 6 with papillary renal cell carcinoma type Ⅱ (PRCC Ⅱ) and 18 with chromophobe renal cell carcinoma (ChRCC). The CT values in different phases in spiral CT multi-phase scanning were measured to calculate the corrected CT values and relative enhancement rates, whose sensitivity and specificity for differentiating the subtypes of renal cell carcinoma were analyzed using receiver operating characteristic (ROC) curve analysis. Results No significant difference was found in unenhanced CT values among different subtypes of renal cell carcinoma. For ccRCC, the corrected CT value was 110.68±45.62 Hu and the corrected relative enhancement rate was 3.19±1.41 in the corticomedullary phase, significantly higher than those of the other subtypes (P < 0.01). In the nephrographic and excretory phases, the corrected CT values of ccRCC were 95.36±25.02 Hu and 74.01±16.10 Hu and the corrected relative enhancement rates were 2.82±1.03 and 2.19±0.71, respectively, all significantly higher than those of PRCC Ⅰ and PRCC Ⅱ (P < 0.05) but comparable with those of ChRCC. The corrected CT value or relative enhancement rate in each phase did not differ significantly between PRCC Ⅰ and PRCC Ⅱ. The corrected CT value and relative enhancement rate of ChRCC in each phase were lower than those of ccRCC but higher than those of PRCC; these values in the corticomedullary phase were significantly higher than those of PRCC Ⅱ (P < 0.05), and the corrected CT value of ChRCC was significantly higher than that of PRCCI and PRCCII (P < 0.05). At the cutoff values of 2.56, 2.28, and 1.25, the relative enhancement rates in the corticomedullary phase had sensitivities of 78.6%, 95.8% and 100.0% for differentiating ccRCC from ChRCC, PRCC Ⅰ and PRCC Ⅱ, with specificities of 94.4%, 78.6% and 92.9%, respectively. At the cutoff value of 1.64, the corrected relative enhancement rate in the nephrographic phase could effectively distinguish ChRCC from PRCC Ⅰ and PRCC Ⅱ with a sensitivity of 75.0% and a specificity of 83.3%. Conclusion The subtypes of renal cell carcinoma have their specific enhancement characteristics. Multi-phase spiral CT scanning has an important value for differentiating these subtypes, and the corrected CT value and relative enhancement rate can help to improve the accuracy of the differential diagnosis, but the differentiation between PRCC Ⅰ and PRCC Ⅱ remains difficult.